Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Aikium Inc.
Aikium is a biotechnology company leveraging its proprietary Yotta-ML² platform, the world's first AI-powered trillion-molecule screening system, to unlock the undruggable proteome. This platform…
Aikium Inc.
Aikium is a biotechnology company leveraging its proprietary Yotta-ML² platform, the world's first AI-powered trillion-molecule screening system, to unlock the undruggable proteome. This platform…
TL;DR
Founded: 2022 (Berkeley, CA)
Tech: AI-driven protein design + ultra-large-scale wet-lab screening (Yotta-ML²)
Focus: Protein therapeutics for hard-to-drug targets (oncology, immune disorders)
Team signal: Leadership from NVIDIA, Harvard, 10X Genomics, NIH, Wyss Institute
Latest raise: Pre-seed $1,525,000 (Nov 15, 2024)
Company Overview
Problem Domain
Designing therapeutics for hard-to-drug targets across oncology, immune disorders, and other challenging diseases.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
1525000
Reported pre-seed raise on Nov 15, 2024; investors include Bantam Group and Fellows Fund among others.
Investor Signal
“Bantam Group, Civilization Ventures, Emerald Bioventures, Fellows Fund, Half Court Ventures, Impact India Investment Partners”